Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Severe COVID-19 increases the risk of hair loss.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Polysaccharides boost immunity and could help prevent and treat diseases.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Bee venom, fig, and geranium oil can effectively treat skin conditions and are safer alternatives to some conventional drugs.

Vitamin D may help reduce thyroid antibodies and improve thyroid function in Hashimoto's Thyroiditis.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Liposomes show promise for delivering CRISPR for gene editing but face challenges like delivery efficiency and safety concerns.

Stem cell serum effectively treated hair loss caused by COVID-19.

New technologies replicate human skin for testing without animals.

New wound healing method using nanoparticles in a gel speeds up healing and reduces infection and inflammation.

People in high-income countries are more likely to accept COVID-19 booster doses than those in middle or low-income countries.

Lower Gas6 and sAxl levels are linked to hair loss in COVID-19 survivors.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

A compound from Sansevieria trifasciata shows strong antibacterial effects against E. coli and S. aureus.

The machine learning model accurately detected hair loss and scalp diseases using processed images.

Frankincense may help treat COVID-19, but more research is needed.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Microneedles could revolutionize pediatric medicine by offering painless drug delivery, but more development is needed.

Wheat extract supplements reduce hair shedding and improve growth in women with hair loss.

The green alga Parachlorella sp. has potential for use in cosmetics and health products due to its antioxidant, anti-hypertensive, and hair growth properties.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.